1
|
Martínez-Torija M, Esteban PF, Santos-De-La-Mata A, Castillo-Hermoso M, Molina-Holgado E, Moreno-Luna R. Multifaceted Pathophysiology and Secondary Complications of Chronic Spinal Cord Injury: Focus on Pressure Injury. J Clin Med 2025; 14:1556. [PMID: 40095463 PMCID: PMC11899819 DOI: 10.3390/jcm14051556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2025] [Revised: 02/19/2025] [Accepted: 02/21/2025] [Indexed: 03/19/2025] Open
Abstract
Background/Objectives: Spinal cord injury (SCI) is a complex medical condition with widespread effects that extend beyond motor and sensory impairments. In addition to nervous system damage, SCI patients experience various secondary complications, including vascular dysfunction, altered body composition, and metabolic disturbances. Among the most common secondary pathologies is the development of pressure injuries (PIs), chronic wounds that significantly affect quality of life and can be challenging to treat. Understanding the physiological and cellular mechanisms behind these complications is crucial for improving care and therapeutic outcomes. Methods: We conducted a comprehensive literature search in PubMed, Scopus, and Google Scholar using keywords related to spinal cord injury, pressure ulcer/pressure injuries, metabolic and vascular dysfunction, biomechanics, and regenerative therapies. Studies were selected based on their relevance to the pathophysiology, risk factors, and novel therapeutic approaches for PIs in SCI patients. Results: Vascular dysfunction, characterized by impaired blood flow and microcirculatory issues, predisposes SCI patients to ischemia and tissue necrosis, particularly in areas subjected to prolonged pressure. Additionally, changes in body composition, such as increased adiposity and muscle atrophy, further compromise tissue integrity and healing capacity. The inflammatory response, mediated by cytokines such as IL-1, IL-6, and TNF-α, exacerbates these effects by sustaining a pro-inflammatory environment that delays the transition of macrophages to the M2 phenotype, critical for wound healing. External factors, such as poor nutrition, infections, and immobility, also play a significant role in worsening the wound healing process. Conclusions: Chronic SCI induces a cascade of physiological changes that predispose patients to the development of PIs and complicate their recovery. The intricate interplay of vascular, metabolic, and inflammatory responses creates a hostile environment for wound healing. A deeper understanding of these systemic effects is essential not only for developing targeted therapeutic strategies to improve chronic wound healing but also for refining preventive approaches that minimize their occurrence. Advancing this knowledge will ultimately help enhance the quality of life for individuals with SCI.
Collapse
Affiliation(s)
- Mario Martínez-Torija
- Pathophysiology and Regenerative Medicine Group, Hospital Nacional de Parapléjicos, SESCAM, 45071 Toledo, Spain; (M.M.-T.); (A.S.-D.-L.-M.); (M.C.-H.)
- Pathophysiology and Regenerative Medicine, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 45004 Toledo, Spain
- Department of Nursing, Hospital Universitario de Toledo, SESCAM, 45071 Toledo, Spain
| | - Pedro F. Esteban
- Grupo de Neuroinflamación, Hospital Nacional de Parapléjicos, SESCAM, 45071 Toledo, Spain; (P.F.E.); (E.M.-H.)
| | - Angela Santos-De-La-Mata
- Pathophysiology and Regenerative Medicine Group, Hospital Nacional de Parapléjicos, SESCAM, 45071 Toledo, Spain; (M.M.-T.); (A.S.-D.-L.-M.); (M.C.-H.)
- Pathophysiology and Regenerative Medicine, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 45004 Toledo, Spain
| | - Matilde Castillo-Hermoso
- Pathophysiology and Regenerative Medicine Group, Hospital Nacional de Parapléjicos, SESCAM, 45071 Toledo, Spain; (M.M.-T.); (A.S.-D.-L.-M.); (M.C.-H.)
- Pathophysiology and Regenerative Medicine, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 45004 Toledo, Spain
- Unit of Internal Medicine and Intermediate Respiratory Care, Hospital Nacional de Parapléjicos, SESCAM, 45071 Toledo, Spain
| | - Eduardo Molina-Holgado
- Grupo de Neuroinflamación, Hospital Nacional de Parapléjicos, SESCAM, 45071 Toledo, Spain; (P.F.E.); (E.M.-H.)
- Grupo de Neuroinflamación, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 45004 Toledo, Spain
| | - Rafael Moreno-Luna
- Pathophysiology and Regenerative Medicine Group, Hospital Nacional de Parapléjicos, SESCAM, 45071 Toledo, Spain; (M.M.-T.); (A.S.-D.-L.-M.); (M.C.-H.)
- Pathophysiology and Regenerative Medicine, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 45004 Toledo, Spain
| |
Collapse
|
2
|
Różańska A, Baranowska-Tateno K, Pac A, Gajda M, Wójkowska-Mach J. Post-discharge surveillance of urinary tract infections in patients following hip and knee arthroplasty: Identifying targets for infection prevention and control. Am J Infect Control 2024; 52:852-856. [PMID: 38583774 DOI: 10.1016/j.ajic.2024.04.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Revised: 04/02/2024] [Accepted: 04/03/2024] [Indexed: 04/09/2024]
Abstract
This population-based study aimed to evaluate the incidence of urinary tract infections following hip and knee arthroplasty (HPRO and KPRO) and identify urinary tract infection risk factors among Polish patients. The analysis included data from 83,525 patients, with incidence rates of 0.7% and 0.49% after HPRO and KPRO, respectively. We identified women, individuals over 65 years old, residents of long-term care facilities, patients with chronic circulatory, endocrine, or digestive diseases, and those operated on due to trauma as targets for infection prevention and control.
Collapse
Affiliation(s)
- Anna Różańska
- Chair of Microbiology, Jagiellonian University Medical College, Kraków, Poland; Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
| | - Katarzyna Baranowska-Tateno
- Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland; Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Kraków, Poland.
| | - Agnieszka Pac
- Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland; Chair in Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Kraków, Poland
| | - Mateusz Gajda
- Chair of Microbiology, Jagiellonian University Medical College, Kraków, Poland; Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
| | - Jadwiga Wójkowska-Mach
- Chair of Microbiology, Jagiellonian University Medical College, Kraków, Poland; Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
| |
Collapse
|